Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB)
CUSIP: 034569103
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 41,587,315
- Total 13F shares
- 7,307,778
- Share change
- +1,413
- Total reported value
- $19,950,292
- Price per share
- $2.73
- Number of holders
- 12
- Value change
- +$326
- Number of buys
- 4
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 034569103?
CUSIP 034569103 identifies ANEB - Anebulo Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 034569103:
Top shareholders of ANEB - Anebulo Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| 22NW, LP |
13F
|
Company |
13%
|
5,366,290
|
$15,401,252 | — | 31 Mar 2024 | |
| LVW Advisors, LLC |
13F
|
Company |
1.5%
|
642,039
|
$1,842,652 | — | 31 Mar 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
1.2%
|
511,073
|
$1,466,780 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.96%
|
399,219
|
$1,145,759 | — | 31 Mar 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.38%
|
157,862
|
$453,064 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.37%
|
153,472
|
$440,465 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.06%
|
25,253
|
$72,476 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
22,777
|
$65,430 | — | 31 Mar 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
18,978
|
$54,467 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
5,138
|
$14,746 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.01%
|
4,049
|
$11,620 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
144
|
$413 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
62
|
$178 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
9
|
$26 | — | 31 Mar 2024 | |
| Simon Allen |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
70,246
|
— | — | 09 Dec 2022 | |
| Karah Herdman Parschauer |
3/4/5
|
Director |
—
class O/S missing
|
30,425
|
— | — | 21 Apr 2022 |
Institutional Holders of Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) as of Q2 2024
As of 30 Jun 2024,
Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,307,778 shares.
The largest 10 holders included
22NW, LP, LVW Advisors, LLC, Nantahala Capital Management, LLC, MORGAN STANLEY, Ikarian Capital, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BOOTHBAY FUND MANAGEMENT, LLC, BlackRock Inc., and Tower Research Capital LLC (TRC).
This page lists
12
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
14
Q2 2024 holders
12
Holder diff
-2
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.